NCT01695252 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Davidson KM, Rankin ML, Begley A, Lloyd S, Barry SJ, McSkimming P, Bell L, Allan C, Osborne M, Ralston G, Bienkowski G, Mellor-Clark J, Walker A
Assessing Patient Progress in Psychological Therapy Through Feedback in Supervision: the MeMOS* Randomized Controlled Trial (*Measuring and Monitoring clinical Outcomes in Supervision: MeMOS). Behav Cogn Psychother. 2017 May;45(3):209-224. doi: 10.1017/S1352465817000029. Epub 2017 Feb 7.

Measuring and Monitoring Patient Informed Clinical Outcomes In Psychological Therapy Supervision - A Stepped Wedge Cluster Randomised Controlled Trial

Details for clinical trial NCT01695252

Clinical trial NCT01695252 - References